Carl Sailer, Director at Acurx Pharmaceuticals, Inc. (ACXP), bought 5,161 shares at $4.84 ($25K) on 2021-11-23, disclosed to the SEC on 2021-11-24.
Open-market purchase of $25k ACXP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ACXP | BUY | 2021-09-10 | $75K | — | Filing → |